Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
European Journal of Dermatology : EJD|April 4, 2006
Cytokines in atopic diseases: revisiting the Th2 dogmaEmilie Mamessier, Antoine MagnanOncoimmunology|February 6, 2014
When breast cancer cells start to fend the educational process of NK cells offEmilie Mamessier, Charlotte Bourgin, Daniel OliveCell Cycle (Georgetown, Tex.)|March 1, 2012
The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancerDavid J Birnbaum, Emilie Mamessier, Daniel BirnbaumOncoimmunology|May 4, 2016
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancersFrançois Bertucci, Pascal Finetti, Daniel Birnbaum, et al.Oncoimmunology|June 28, 2012
"Stealth" tumors: Breast cancer cells shun NK-cells anti-tumor immunityEmilie Mamessier, François Bertucci, Renaud Sabatier, et al.International Journal of Molecular Sciences|November 27, 2024
Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision TherapiesMaria Kfoury, Pascal Finetti, Emilie Mamessier, et al.Journal of Clinical Medicine|May 5, 2019
<i>XPO1</i> Expression Is a Poor-Prognosis Marker in Pancreatic AdenocarcinomaDavid Jérémie Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.Cancers|April 11, 2019
Head and Body/Tail Pancreatic Carcinomas Are Not the Same TumorsDavid Jérémie Birnbaum, François Bertucci, Pascal Finetti, et al.Molecular Cancer|November 8, 2017
Validation and comparison of the molecular classifications of pancreatic carcinomasDavid J Birnbaum, Pascal Finetti, Daniel Birnbaum, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|March 3, 2018
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancerDavid J Birnbaum, François Bertucci, Pascal Finetti, et al.Pageof 9